Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Odero

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 28, 2015
GATA2 germline mutations impair GATA2 transcription, causing haploinsufficiency: functional analysis of the p.Arg396Gln mutationXabier Cortés-Lavaud, Manuel F Landecho, Miren Maicas, et al.
Plos One|October 15, 2011
3'UTR-mediated gene silencing of the Mixed Lineage Leukemia (MLL) geneMaria Gomez-Benito, Fabricio Loayza-Puch, Joachim A F Oude Vrielink, et al.
Science Translational Medicine|July 19, 2019
Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia"Danilo Perrotti, Anupriya Agarwal, Claire M Lucas, et al.
Haematologica|December 3, 2011
Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemiaIon Cristóbal, Laura Garcia-Orti, Cristina Cirauqui, et al.
Plos One|October 19, 2012
Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemiaLaura García-Ortí, Ion Cristóbal, Cristina Cirauqui, et al.
Blood|May 16, 1998
Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridizationJ C Cigudosa, P H Rao, M J Calasanz, et al.
Cancers|May 16, 2023
Set Protein Is Involved in FLT3 Membrane TraffickingNerea Marcotegui, Silvia Romero-Murillo, Javier Marco-Sanz, et al.
Genes, Chromosomes & Cancer|May 13, 2004
Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangementsIdoya Lahortiga, Iria Vázquez, Xabier Agirre, et al.
Oncogene|June 13, 2012
Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcriptionM Maicas, I Vázquez, C Vicente, et al.
British Journal of Haematology|April 2, 2005
p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IVMikel Valgañón, Pilar Giraldo, Xabier Agirre, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|January 28, 2015
GATA2 germline mutations impair GATA2 transcription, causing haploinsufficiency: functional analysis of the p.Arg396Gln mutationXabier Cortés-Lavaud, Manuel F Landecho, Miren Maicas, et al.
Plos One|October 15, 2011
3'UTR-mediated gene silencing of the Mixed Lineage Leukemia (MLL) geneMaria Gomez-Benito, Fabricio Loayza-Puch, Joachim A F Oude Vrielink, et al.
Science Translational Medicine|July 19, 2019
Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia"Danilo Perrotti, Anupriya Agarwal, Claire M Lucas, et al.
Haematologica|December 3, 2011
Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemiaIon Cristóbal, Laura Garcia-Orti, Cristina Cirauqui, et al.
Plos One|October 19, 2012
Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemiaLaura García-Ortí, Ion Cristóbal, Cristina Cirauqui, et al.
Blood|May 16, 1998
Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridizationJ C Cigudosa, P H Rao, M J Calasanz, et al.
Cancers|May 16, 2023
Set Protein Is Involved in FLT3 Membrane TraffickingNerea Marcotegui, Silvia Romero-Murillo, Javier Marco-Sanz, et al.
Genes, Chromosomes & Cancer|May 13, 2004
Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangementsIdoya Lahortiga, Iria Vázquez, Xabier Agirre, et al.
Oncogene|June 13, 2012
Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcriptionM Maicas, I Vázquez, C Vicente, et al.
British Journal of Haematology|April 2, 2005
p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IVMikel Valgañón, Pilar Giraldo, Xabier Agirre, et al.
Pageof 8